The role of SPRTN protease in colorectal cancer chemotherapy

The role of SPRTN protease in colorectal cancer chemotherapy

<p>Colorectal cancer (CRC) currently represents one of the most commonly diagnosed tumors, accounting for 10% of all cancer diagnoses and cancer-related deaths. The first-line treatment of metastatic colorectal cancer (mCRC) is frequently based on combination chemotherapeutic regimens, where 5...

Bibliografski detalji
Glavni autor:	Peron, C
Daljnji autori:	Ramadan, K
Format:	Disertacija
Jezik:	English
Izdano:	2023
Teme:	Cancer Oncology

Slični predmeti

SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells
od: Na, J, i dr.
Izdano: (2021)

The Effect Of Chemotherapy On Malnutrition In Geriatric Group With Metastatic Colorectal Cancer
od: Esat Namal
Izdano: (2019-01-01)

SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication
od: Halder, S, i dr.
Izdano: (2019)

Mechanisms and Regulation of DNA-Protein Crosslink Repair During DNA Replication by SPRTN Protease
od: Megan Perry, i dr.
Izdano: (2022-06-01)

The role of p97 cofactors SPRTN and FAF1 in DNA replication
od: Halder, S
Izdano: (2016)

Colorectal cancer - Progress rehabilitation after surgery
od: Agnieszka Filarecka, i dr.
Izdano: (2019-09-01)

Colorectal cancer - Progress rehabilitation after surgery
od: Agnieszka Filarecka, i dr.
Izdano: (2019-09-01)

Colorectal cancer: the EMT transcription factor ZEB1, the interaction between myofibroblast and colorectal cancer cells and GMM analysis of cancer gene expression
od: Liu, T
Izdano: (2021)

Goblet cell differentiation in colorectal cancer
od: Abdullayeva, G
Izdano: (2023)

DNA damage repair proteins as determinants of sensitivity to platinum chemotherapy
od: MacGregor, T
Izdano: (2016)

Stratifiers for oxaliplatin outcome in colorectal cancer
od: Hassanieh, S
Izdano: (2021)

Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways
od: J. Russell Hoverman
Izdano: (2020-08-01)

Multi-platform-based characterization of ferroptosis in human colorectal cancer
od: Yafang Zhong, i dr.
Izdano: (2022-08-01)

Innovating supportive nutrition assessment for pediatric cancer patients undergoing radio-chemotherapy
od: Ateya Megahed Ibrahim, i dr.
Izdano: (2024-01-01)

Evaluating the Outcomes in Patients with Colorectal Cancer Using the Malnutrition Universal Screening Tool: A Systematic Review
od: Muntean C, i dr.
Izdano: (2024-09-01)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
od: Lan G. Coffman, i dr.
Izdano: (2022-09-01)

Patient‐reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment
od: Taiwo Adesoye, i dr.
Izdano: (2023-09-01)

Tyrosyl-DNA phosphodiesterase 1 (TDP1) and SPRTN protease repair histone 3 and topoisomerase 1 DNA–protein crosslinks in vivo
od: Ivan Anticevic, i dr.
Izdano: (2023-10-01)

Impact of Chemotherapy-Induced Peripheral Neuropathy on the Quality of Life in Cancer Patients
od: Marica Novak, i dr.
Izdano: (2022-01-01)

HOPE OF WOMEN UNDERGOING CHEMOTHERAPY TREATMENT FOR BREAST CANCER
od: Eduardo Tavares Gomes, i dr.
Izdano: (2019-12-01)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
od: Thyla Viswanathan, i dr.
Izdano: (2021-12-01)

SPRTN metalloprotease participates in repair of ROS-mediated DNA-protein crosslinks
od: Luke Erber, i dr.
Izdano: (2024-12-01)

Partners’ engagement in surveillance among survivors of colorectal cancer: A qualitative study
od: Christine M. Veenstra, i dr.
Izdano: (2021-02-01)

Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
od: Timothée Olivier, i dr.
Izdano: (2023-09-01)

Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
od: Shalu Kasliwal, i dr.
Izdano: (2024-01-01)

Oncological aid for colorectal cancer patients in Tomsk area: ways of cancer prevention
od: L. D. Zhuykova, i dr.
Izdano: (2014-12-01)

Genetic predisposition in chemotherapy‐induced cardiomyopathy in a 65‐year‐old female with metastatic breast cancer
od: So‐Young Lee, i dr.
Izdano: (2024-08-01)

Elements of human cancer /
od: 311669 Cooper, Geoffrey M.
Izdano: (1992)

SPRTN is a mammalian DNA-binding metalloprotease that resolves DNA-protein crosslinks
od: Jaime Lopez-Mosqueda, i dr.
Izdano: (2016-11-01)

The role of fibroblast ENPP1 expression on anti-tumour immunity
od: Vadibeler, S
Izdano: (2023)

The Gale Encyclopedia of Cancer /
od: Longe, Jacqueline L. editor 422209, i dr.
Izdano: (2010)

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer
od: Ipshita Prakash, i dr.
Izdano: (2022-02-01)

THE ROLE OF PHYSIOTHERAPY IN CANCER CARE IN THE EUROPE REGION: A POSITION PAPER OF THE CANCER WORKING GROUP OF EUROPE REGION WORLD PHYSIOTHERAPY
od: Nele Adriaenssens, i dr.
Izdano: (2023-06-01)

THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
od: A. A. Rumyantsev, i dr.
Izdano: (2015-09-01)

Exosomal proteases in colorectal cancer
od: E. A. Zambalova, i dr.
Izdano: (2019-01-01)

The process of physiotherapy in patients treated for colorectal cancer
od: Agnieszka Filarecka, i dr.
Izdano: (2021-09-01)

Cellular adaptations to low extracellular pH in the microenvironment of colorectal cancer and other solid tumours
od: White, B
Izdano: (2024)

The latest treatment of colorectal cancer - a review paper
od: Anna Wojtkiewicz, i dr.
Izdano: (2024-10-01)

Editorial: The use of chemotherapy in treating gastric cancers
od: Lei Huang, i dr.
Izdano: (2022-07-01)

SPRTN patient variants cause global-genome DNA-protein crosslink repair defects
od: Pedro Weickert, i dr.
Izdano: (2023-01-01)